VULLO, VITTORIA
 Distribuzione geografica
Continente #
EU - Europa 139
NA - Nord America 62
AS - Asia 52
SA - Sud America 25
AF - Africa 1
Totale 279
Nazione #
RU - Federazione Russa 118
US - Stati Uniti d'America 60
BR - Brasile 21
SG - Singapore 19
VN - Vietnam 11
CN - Cina 8
GB - Regno Unito 7
IT - Italia 6
BD - Bangladesh 4
KR - Corea 4
EC - Ecuador 3
PL - Polonia 3
FR - Francia 2
HK - Hong Kong 2
AR - Argentina 1
AT - Austria 1
BW - Botswana 1
CA - Canada 1
DE - Germania 1
GT - Guatemala 1
ID - Indonesia 1
PH - Filippine 1
SE - Svezia 1
TM - Turkmenistan 1
TR - Turchia 1
Totale 279
Città #
San Jose 14
Moscow 13
Singapore 10
Ashburn 8
Hanoi 4
Ho Chi Minh City 4
London 4
Beijing 3
Buffalo 3
Chicago 3
Naples 3
Seoul 3
The Dalles 3
Hillsboro 2
Hong Kong 2
Los Angeles 2
Portsmouth 2
Warsaw 2
Yubileyny 2
Araucária 1
Araçatuba 1
Ashgabat 1
Atlanta 1
Bexley 1
Biên Hòa 1
Boston 1
Bremen 1
Bricktown 1
Brooklyn 1
Cabo Frio 1
Cagayan de Oro 1
Cajazeiras 1
Campinas 1
Catania 1
Cầu Giấy 1
Delmiro Gouveia 1
Elk Grove Village 1
Frankfurt am Main 1
Gaborone 1
Goiânia 1
Greenville 1
Guarapuava 1
Guatemala City 1
Guayaquil 1
Inaciolândia 1
Indpls 1
Itaquaquecetuba 1
Lauterbourg 1
Macaé 1
Milan 1
Milwaukee 1
New York 1
Orem 1
Ourinhos 1
Palotina 1
Paranavaí 1
Petrolina 1
Pinhais 1
Pinheiro 1
Presidente Prudente 1
Quevedo 1
Quito 1
Rome 1
Rosario 1
San Francisco 1
Santa Clara 1
Seattle 1
Secaucus 1
Stockholm 1
São João del Rei 1
São Paulo 1
Tampa 1
Thái Nguyên 1
Van 1
Vienna 1
Vitória da Conquista 1
Wroclaw 1
Yonkers 1
Totale 146
Nome #
Treatment simplification to atazanavir/ritonavir+lamivudine versus maintenance of atazanavir/ritonavir+two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 105
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 96
Safety and efficacy of treatment switch to raltegravir plus tenofovir/emtricitabine or abacavir/lamivudine in patients with optimal virological control: 48-week results from a randomized pilot study (Raltegravir Switch for Toxicity or Adverse Events, RASTA Study) 81
Totale 282
Categoria #
all - tutte 1.429
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.429


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025153 0 0 6 1 3 17 81 29 8 2 3 3
2025/2026129 11 7 22 20 5 2 6 9 13 8 14 12
Totale 282